The novel approach of tirzepatide peptide represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatide-peptide930044.ssnblog.com/40585013/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment